@conference {W05-02,
	title = {W05-02: Therapeutic Indications and Other Use-case-driven Updates in the Drug Ontology},
	booktitle = {International Conference on Biomedical Ontology and BioCreative (ICBO BioCreative 2016)},
	series = {Proceedings of the Joint International Conference on Biological Ontology and BioCreative (2016)},
	year = {2016},
	month = {11/30/16},
	publisher = {CEUR-ws.org Volume 1747},
	organization = {CEUR-ws.org Volume 1747},
	abstract = {The Drug Ontology (DrOn) is a an OWL2-based representation of drug products and their ingredients, mechanisms of action, strengths, and dose forms, as well as of packaged drug products as represented by United States National Drug Codes (NDCs) [1-3]. The primary goal of DrOn is to support analyses of large, drug-related datasets such as pharmacy claims and EHR data.},
	url = {http://icbo.cgrb.oregonstate.edu/},
	author = {William R. Hogan and Josh Hanna and Amanda Hicks and Samira Amirova and Baxter Bramblett and Matthew Diller and Rodel Enderez and Timothy Modzelewski and Mirela Vasconcelos and Chris Delcher}
}
@conference {IP02,
	title = {IP02: Adding evidence type representation to DIDEO},
	booktitle = {International Conference on Biomedical Ontology and BioCreative (ICBO BioCreative 2016)},
	series = {Proceedings of the Joint International Conference on Biological Ontology and BioCreative (2016)},
	year = {2016},
	month = {11/30/16},
	publisher = {CEUR-ws.org Volume 1747},
	organization = {CEUR-ws.org Volume 1747},
	abstract = {<p>In this poster we present novel development and extension of the Drug-drug Interaction and Drug-drug Interaction Evidence Ontology (DIDEO). We demonstrate how reasoning over this extension of DIDEO can a) automatically create a multi-level hierarchy of evidence types from descriptions of the underlying scientific observations and b) automatically subsume individual evidence items under the correct evidence type. Thus DIDEO will enable evidence items added manually by curators to be automatically categorized into a drug-drug interaction framework with precision and minimal effort from curators. As with all previous DIDEO development this extension is consistent with OBO Foundry principles.</p>
},
	url = {http://ceur-ws.org/Vol-1747/IP02_ICBO2016.pdf},
	author = {Mathias Brochhausen and Philip E. Empey and Jodi Schneider and William R. Hogan and Richard D. Boyce}
}
